CULLETTA, Giulia
 Distribuzione geografica
Continente #
NA - Nord America 134
EU - Europa 104
AS - Asia 31
Totale 269
Nazione #
US - Stati Uniti d'America 133
IE - Irlanda 58
IT - Italia 29
SE - Svezia 17
SG - Singapore 16
CN - Cina 8
ID - Indonesia 3
HK - Hong Kong 2
CA - Canada 1
IN - India 1
JP - Giappone 1
Totale 269
Città #
Chandler 73
Dublin 58
Nyköping 17
Palermo 14
Singapore 11
Princeton 8
Ashburn 7
Messina 6
Cagliari 4
Medford 3
Des Moines 2
Surabaya 2
Catania 1
Hangzhou 1
Jakarta 1
Jinan 1
Los Angeles 1
Milan 1
Montreal 1
Piazza Armerina 1
Tianjin 1
Washington 1
Wilmington 1
Totale 216
Nome #
Design, synthesis, biological evaluation,and molecular modeling of inhibitors of enzymes involved in tumor and viral pathologies 55
Uno studio comparativo in silico sui possibili target di Ataluren e analoghi farmaci promotori di readthrough di codoni di stop prematuri 38
Immunoproteasome and Non-Covalent Inhibition: Exploration by Advanced Molecular Dynamics and Docking Methods 35
Exploring the SARS-CoV-2 proteome in the search of potential inhibitors via structure-based pharmacophore modeling/docking approach 35
Exploring the non-covalent ligand-binding mechanism on immunoproteasome by enhanced Molecular Dynamics 35
In Silico Design, Synthesis and Biological Evaluation of Anticancer Arylsulfonamide Endowed with Anti-Telomerase Activity 27
CHA on CDK2: a way to identify the best pharmacophore model for the virtual screening of new inhibitors 25
TOWARD ENRICHED VHTS FOR CDK2 INHIBITORS: MOLECULAR DYNAMICS, PHARMACOPHORE MODELLING, AND DOCKING 19
Sulfonamide Moiety as “Molecular Chimera” in the Design of New Drugs 14
null 6
Totale 289
Categoria #
all - tutte 1.473
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.473


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20216 0 0 0 0 0 0 0 0 4 2 0 0
2021/202230 2 1 0 2 0 1 2 2 0 0 6 14
2022/2023188 9 13 8 41 3 28 8 10 61 0 6 1
2023/202446 1 9 5 11 2 1 1 5 0 2 0 9
2024/202519 0 6 2 10 1 0 0 0 0 0 0 0
Totale 289